Background: The arginine test is used for the diagnosis of growth hormone deficiency (GHD), but its duration is not uniform and varies from 180 to 90 min. Subjects and Methods: To standardize this test, evaluating the possibility to shorten it to 90 min, we investigated the response of GH to the arginine test in 208 children evaluated for short stature (height less than –2 SD); 67 were diagnosed with idiopathic short stature (ISS) and 141 with GHD. We calculated the frequency distribution of the GH peaks to arginine in GHD and in ISS at various times and the percentage of GH peaks to arginine before and after 90 min in all and in ISS children. Results: The GH peak distribution varied between 30 and 120 min, even though the vast majority of peaks occurred between 30 and 90 min. There was no significant difference (p > 0.05) in the peak distribution between ISS and GHD children. The percentages of GH peaks within 90 min were 95.2% in all children and 100% in ISS. Conclusion: The arginine test can be administered for only 90 min without significantly changing its validity, in order to reduce the discomfort of patients and the cost of the test.

Keywords:
Growth hormone provocative tests, Growth hormone deficiency, Clonidine, Arginine, Short stature
1.
Growth Hormone Research Society: Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000;85:3990–3993.
2.
Sizoneko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z: Diagnosis and management of growth hormone deficiency in childhood and adolescence. 1. Diagnosis of growth hormone deficiency. Growth Horm IGF Res 2001;11:137–165.
3.
Guyda HJ: Growth hormone testing and the short children. Pediatr Res 2000;48:579–580.
4.
Gil-Ad I, Topper E, Laron Z: Oral clonidine as a growth hormone stimulation test. Lancet 1979;ii:278–279.
5.
Salti R, Galluzzi F, Becherucci P, Seminara S, Calzolari C, Innocenti S, La Cauza C: Oral clonidine: an effective provocative test of growth hormone release. Helv Paediatr Acta 1981;36:527–531.
6.
Pinchera A, Bertagna X, Fischer J, Groop L, Serio M: Clinical Medicine Series: Endocrinology and Metabolism. New York, McGraw Hill, 2001.
7.
Tetlow LJ, Clayton PE: Tests and normal values in pediatric endocrinology; in Brook C, Clayton P, Brown R (eds): Brook’s Clinical Pediatric Endocrinology, ed 5. Oxford, Blackwell, 2005, p 523.
8.
Shalet SM, Toogood A, Rahim A, Brennan BM: The diagnosis of growth hormone deficiency in children and adults. Endocrinol Rev 1998;19:203–223.
9.
Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity and the stages of puberty. Arch Dis Child 1976;51:170–179.
10.
Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.
11.
Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.
12.
Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist, ed 2. Stanford, Stanford University Press, 1959.
13.
Pombo Arias M: Manual de Pediatria Practica. Madrid, Ediciones Díaz de Santos, 1992.
14.
Rocchiccioli P, Enjaume C, Tauber MT, Pienkowski C: Statistical study of 5,473 results of nine pharmacological stimulation tests: a proposed weighting index. Acta Paediatr 1993;82:245–248.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.